Molecular interpretation
POAS reads existing molecular reports across six analytical layers for clinician-led assessment.
Learn more
About KPCIRC
Built to support the doctor behind every patient journey.
Kwatra Precision Cancer Institute & Research Centre (KPCIRC) is a clinical services and physician-collaboration platform with one focus: precision oncology. It brings clinical review, molecular interpretation, complementary services and defined collaboration pathways into a coordinated framework.
Precision oncology is our focus. Every service connects to a more informed understanding of cancer.
KPCIRC works within agreed service boundaries and seeks continuity with the treating clinician. Its services are designed to support the clinical team and the patient’s care pathway, not to displace existing responsibilities by default.
Our vision
Every cancer decision more informed, individualised and accountable, so that every patient can be considered for every appropriate option within the evidence and their clinical circumstances.
What guides our work
People
Clinical expertise and the patient’s circumstances remain central to the care conversation.
Perspective
Complex cases may need more than one view. Structured review brings relevant information and questions together.
Partnership
We work with treating clinicians and institutions through defined responsibilities and agreed workflows.
Progress
Clear interpretation, timely reassessment and connected follow-up help organise evolving clinical questions.
What KPCIRC connects
Multidisciplinary clinical review
Molecular Tumour Board review, second opinions and progression review around defined questions.
Learn more
Institutional oncology support
Defined arrangements with hospitals and nursing homes, built around real capability.
Learn more
Patient pathways and research
Cancer care, genetics and risk, and translational research themes connected to clinical questions.
Learn more
Founder and leadership
Dr Bharat Kwatra
Founder & Managing Director, KPCIRC
Dr Bharat Kwatra’s work focuses on cancer genomics, computational biology and precision-oncology analysis. At KPCIRC, he leads the institute’s precision-focused strategy and helps structure molecular evidence review, multidisciplinary collaboration and complementary oncology service pathways.
This profile describes a leadership and computational precision-oncology role. It does not describe a treating-clinician role unless one is separately confirmed.
Research and innovation
KPCIRC’s areas of interest include cancer genomics, circulating tumour DNA (ctDNA), multi-omic analysis, AI-enabled bioinformatics, molecular interpretation, clinical-trial matching and digital-twin oncology. Active clinical services are kept clearly separate from research, investigational workflows and technology development.
Short explainers, in production
- KPCIRC in 90 secondsAbout 90 seconds